Skip to content
Lulizumab pegol
Lulizumab pegol is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against T-cell-specific surface glycoprotein CD28.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Sjogren's syndromeD012859EFO_0000699M35.0—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—1————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLULIZUMAB PEGOL
INNlulizumab pegol
Description
Lulizumab pegol (humanized mab)
Classification
Antibody
Drug classmonoclonal antibodies; PEGylated compounds, covalent attachment of macrogol (polyethylene glycol) polymer
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL3137354
ChEBI ID—
PubChem CID—
DrugBank—
UNII IDLCT264LTYE (ChemIDplus, GSRS)
Target
Agency Approved
CD28
CD28
Organism
Homo sapiens
Gene name
CD28
Gene synonyms
NCBI Gene ID
940
Protein name
T-cell-specific surface glycoprotein CD28
Protein synonyms
CD28, TP44
Uniprot ID
P10747
Mouse ortholog
Cd28 (12487)
T-cell-specific surface glycoprotein CD28 (Q6GSH7)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 16 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details